Some studies have reported the role of CCNB1, CCNB2, PTTG1, RACGAP1, and UBE2C in cell cycle regulation, aggressive tumor behavior, a poor prognosis, resistance to therapy, and cancer stem cell regulation in breast cancer. Here, UBE2C is linked to breast carcinoma.